With the popular social media app once again at risk of going dark, there are best practices pharma brands can use on other ...

Existing research indicates that the accuracy of a Parkinson’s disease diagnosis hovers between 55% and 78% in the first five years of assessment. That’s partly because Parkinson’s sibling movement ...

The Department of Justice (DoJ) claims that Biohaven – before being acquired ... will use every tool at its disposal to prevent pharmaceutical manufacturers from undermining the objectivity ...

Amvuttra’s clearance in a rare form of cardiomyopathy could help Alnylam turn a regular profit — if it can wrest control of a ...

NEW YORK, NY / ACCESS Newswire / March 16, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Biohaven Ltd. ("Biohaven Ltd.") (NYSE:BHVN) concerning possible ...

The four therapies – Biohaven's myeloperoxidase inhibitor verdiperstat, Prilenia Therapeutics' sigma-1 receptor agonist pridopidine, Clene Nanomedicine's gold nanocrystal therapy CNM-Au8 ...

After hours: March 19 at 6:54:53 PM EDT Loading Chart for BHVN ...

Exclusive: Gates warns White House he can't fill shortfalls in US global health funding Bill Gates is personally lobbying Trump administration officials to keep funding health programs worldwide ...

After hours: March 12 at 7:12:45 p.m. EDT Loading Chart for BHVN ...